A FRET-based cGMP biosensor in Drosophila.

Ana Clara Gonzalez1, Cecilia Abreu2, Sergio Pantano3

  • 1Departamento de Biología del Neurodesarrollo, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Montevideo, Uruguay.

Micropublication Biology
|December 14, 2023
PubMed
Summary

Researchers developed transgenic Drosophila strains expressing the CUTie2 biosensor for studying cyclic guanosine monophosphate (cGMP) signaling in whole organisms. This FRET-based tool shows rapid, reversible responses, validating its use in multicellular contexts.

Related Concept Videos